Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 15;11(7):647.
doi: 10.3390/v11070647.

Haemostatic Changes in Five Patients Infected with Ebola Virus

Affiliations

Haemostatic Changes in Five Patients Infected with Ebola Virus

Sophie J Smither et al. Viruses. .

Abstract

Knowledge on haemostatic changes in humans infected with Ebola virus is limited due to safety concerns and access to patient samples. Ethical approval was obtained to collect plasma samples from patients in Sierra Leone infected with Ebola virus over time and samples were analysed for clotting time, fibrinogen, and D-dimer levels. Plasma from healthy volunteers was also collected by two methods to determine effect of centrifugation on test results as blood collected in Sierra Leone was not centrifuged. Collecting plasma without centrifugation only affected D-dimer values. Patients with Ebola virus disease had higher PT and APTT and D-dimer values than healthy humans with plasma collected in the same manner. Fibrinogen levels in patients with Ebola virus disease were normal or lower than values measured in healthy people. Clotting times and D-dimer levels were elevated during infection with Ebola virus but return to normal over time in patients that survived and therefore could be considered prognostic. Informative data can be obtained from plasma collected without centrifugation which could improve patient monitoring in hazardous environments.

Keywords: APTT; D-dimers; Ebola virus; PT; clotting; fibrinogen; haemostasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Effect of collection method on four haemostatic parameters. Naïve blood samples were collected from healthy UK volunteers and analysed for Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), fibrinogen, and D-dimer amounts. Plasma was obtained by centrifugation (standard method) or by non-centrifugation where blood was left to separate over time. Non-centrifuged plasma was collected for comparison with Ebola virus-infected plasma samples collected without centrifugation. Each test was run in duplicate and both values are shown. For some centrifuged samples, multiple aliquots from the same donor were analysed on different occasions, each individual result is also shown. Mean and SEM (coloured lines and bars) are shown for each data set. Unpaired t-tests were performed to compare the results from the two collection methods.
Figure 2
Figure 2
Changes in haemostasis parameters over time in Ebola virus-infected individuals. Mean values of Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) (top row) and fibrinogen, and D-Dimer values (bottom row) from plasma samples collected without centrifugation from five patients are shown. Each time-point was tested in at least duplicate and mean plotted. Each patient is represented by a different colour and symbol and days of sampling post-symptom onset were different for each patient. Grey shaded area indicates the range of values for each test obtained from naïve ‘normal’ human donor samples also collected without centrifugation (Figure 1). Dashed line is the mean value from the un-centrifuged non-infected samples and the dotted line is the value of the un-centrifuged mean + 3 standard deviations (for fibrinogen—3 standard deviations also shown with a second dotted line). If data distribution is approximately normal, then 99.7 % lies within three standard deviations. One PT result and several D-dimer results were out of range and are plotted at the upper limit of the test and indicated as such for each data set.

References

    1. Nyakarahuka L., Kankya C., Krontveit R., Mayer B., Mwiine F.N., Lutwama J., Skjerve E. How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence. BMC Infect. Dis. 2016;16:708. doi: 10.1186/s12879-016-2045-6. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention (CDC) Guidance for U.S. Laboratories for Managing and Testing Routine Clinical Specimens When There Is a Concern about Ebola Virus Disease. [(accessed on 23 April 2019)]; Available online: http://www.cdc.gov/vhf/ebola/healthcare-us/laboratories/safe-specimen-ma....
    1. Schieffelin J.S., Shaffer J.G., Goba A., Gbakie M., Gire S.K., Colubri A., Sealfon R.S., Kanneh L., Moigboi A., Momoh M., et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N. Engl. J. Med. 2014;371:2092–2100. doi: 10.1056/NEJMoa1411680. - DOI - PMC - PubMed
    1. Hunt L., Gupta-Wright A., Simms V., Tamba F., Knott V., Tamba K., Heisenberg-Mansaray S., Tamba E., Sheriff A., Conteh S. Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: An observational cohort study. Lancet Infect. Dis. 2015;15:1292–1299. doi: 10.1016/S1473-3099(15)00144-9. - DOI - PubMed
    1. Isaacson M., Sureau P., Courteille G., Pattyn S.R. Clinical aspects of Ebola virus disease at the Ngaliema hospital, Kinshasa, Zaire, 1976. In: Pattyn S.R., editor. Ebola Virus Haemorrhagic Fever. Elsevier/North-Holland Biomedical Press; New York, NY, USA: 1978. pp. 15–20.

Publication types

Substances

LinkOut - more resources